1 line
2.7 KiB
JSON
1 line
2.7 KiB
JSON
{"acute pulmonary oedema": 6.69, "adverse drug reaction": 2.3, "adverse event": 3.36, "anaemia": 3.02, "anaphylactic shock": 2.91, "anaphylactoid reaction": 6.06, "asphyxia": 15.74, "atrial fibrillation": 3.05, "atrial flutter": 3.37, "bronchospasm": 19.55, "chest discomfort": 2.61, "coombs indirect test positive": 605.44, "crossmatch incompatible": 3494.36, "cytomegalovirus infection": 6.86, "cytomegalovirus infection reactivation": 5.68, "cytopenia": 9.37, "disease progression": 7.74, "drug reaction with eosinophilia and systemic symptoms": 2.16, "dyspnoea": 2.16, "encephalopathy": 2.34, "extravasation": 38.73, "febrile neutropenia": 4.57, "granulocyte count decreased": 12.04, "haematotoxicity": 4.12, "haemoglobin decreased": 2.79, "haemolysis": 2.44, "hepatic cytolysis": 2.1, "hypercalcaemia": 3.53, "hyperpyrexia": 2.14, "hypersensitivity": 2.02, "hypervolaemia": 3.25, "hypogammaglobulinaemia": 17.0, "hypoxia": 5.5, "incorrect drug administration rate": 16.43, "infection": 3.76, "infusion related reaction": 149.48, "infusion site extravasation": 16.36, "intentional product use issue": 10.39, "laryngeal oedema": 7.25, "leukopenia": 2.46, "light chain analysis increased": 175.31, "lymphocyte count decreased": 3.7, "lymphopenia": 10.3, "monoclonal immunoglobulin present": 100.11, "myelosuppression": 5.39, "nasal congestion": 3.33, "nasal obstruction": 18.63, "neuropathy peripheral": 8.01, "neutropenia": 6.64, "neutrophil count decreased": 7.73, "off label use": 4.62, "oropharyngeal discomfort": 2.61, "osteonecrosis of jaw": 4.47, "oxygen saturation decreased": 9.39, "pancytopenia": 6.29, "peripheral sensory neuropathy": 6.41, "plasma cell leukaemia": 63.07, "plasma cell myeloma": 144.35, "plasma cell myeloma recurrent": 76.57, "plasmacytoma": 75.38, "platelet count decreased": 5.33, "pneumocystis jirovecii pneumonia": 3.11, "pneumonia": 4.06, "polyneuropathy": 10.05, "posterior reversible encephalopathy syndrome": 3.16, "product dose omission issue": 2.42, "product use in unapproved indication": 4.21, "product use issue": 5.28, "pulmonary oedema": 2.03, "respiratory disorder": 2.91, "respiratory distress": 3.04, "respiratory failure": 2.22, "respiratory tract infection": 2.06, "rhinorrhoea": 3.2, "sepsis": 4.11, "septic shock": 4.34, "sinus tachycardia": 2.14, "sneezing": 2.13, "stem cell transplant": 58.74, "tachypnoea": 10.61, "temperature intolerance": 24.45, "therapeutic product effect incomplete": 2.35, "therapeutic response decreased": 2.15, "throat irritation": 2.93, "throat tightness": 2.14, "thrombocytopenia": 5.07, "transfusion": 4.17, "tumour lysis syndrome": 14.29, "underdose": 2.65, "upper respiratory tract infection": 3.11, "wheezing": 4.57, "white blood cell count decreased": 4.07} |